delamanid expanded access novel treatment of drug resistant tuberculosis [corrigendum]
;Rustomjee R;Zumla A
clinical gastroenterology and hepatology : the official clinical practice journal of the american gastroenterological association2016Vol. 2016pp. 43-45
70
r2016infectiondelamanid
Abstract
Rustomjee R, Zumla A. Delamanid expanded access novel treatment of drug resistant tuberculosis. Infection and Drug Resistance. 2015;8:359–366. Dr Rustomjee and Professor Zumla are grateful to a reader for raising some issues regarding referencing, and interpretation of their paper, and would like to clarify and address these issues. Read the original article